People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Biotech / Pharma, Agriculture, Biotechnology, Robotics, Software / Tech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Greenlight Biosciences Inc. | — | Biotech / Pharma | Series D+ | $179.4M | $3.9B | 2018 |
| Hazel Technologies, Inc. | — | Agriculture | Series C | $102.6M | $49.0M | 2019 |
| Shenandoah Valley Organic, LLC | — | Agriculture | Series B | $83.1M | $32.0M | 2022 |
| Solarea Bio, Inc. | — | Biotechnology | Series A | $37.2M | $27.2M | 2020 |
| Accel Robotics Corp | — | Robotics | Series A | $11.4M | $138.1M | 2018 |
| WENN Digital, Inc. | — | Software / Tech | Series A | $6.8M | $187.2M | 2018 |
| Mercaris Corp | — | Other | Seed | $6.7M | $71.7M | 2018 |
| OneClickShip, Inc. | — | Other Technology | Series A | $5.3M | $70.4M | 2022 |
| Peninsula Capital Corp. | — | Other | Pre-Seed | $1.6M | $1.4M | 2025 |
| Dock Fund, LP | — | Retailing | Seed | $1.4M | $8.8M | 2012 |
| Resource Nation Inc | — | Other | Pre-Seed | $343K | $572K | — |
Matthew Walker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Walker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sanjeev Krishnan | 1 | 11 |
| Jan Bouten | 1 | 10 |
| Michael Liang | 1 | 9 |
| Kevin Murphy | 1 | 9 |
| Jonathan Fleming | 1 | 9 |
| Jason Dinges | 1 | 8 |
| David Furneaux | 1 | 8 |
| Patrick Flynn | 1 | 8 |
| ROBERT MACDONALD | 1 | 7 |
| Ganesh Kishore | 1 | 7 |
| CAMERON CHELL | 1 | 6 |
| Eric O'Brien | 1 | 6 |
| Andrey Zarur | 1 | 6 |
| Carsten Boers | 1 | 5 |
| Anula Jayasuriya | 1 | 5 |
| Neil Renninger | 1 | 4 |
| Brian McLaughlin | 1 | 4 |
| Charles L. Cooney | 1 | 4 |
| Laura Markley | 1 | 4 |
| Charles Cooney | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.